Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment (vol 12, pg 134, 2010)

被引:7
|
作者
Hecker, M.
Goertsches, R. H.
Fatum, C.
Koczan, D.
Thiesen, H-J
Guthke, R.
Zettl, U. K.
机构
来源
PHARMACOGENOMICS JOURNAL | 2012年 / 12卷 / 04期
关键词
D O I
10.1038/tpj.2011.12
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Correction to: The Pharmacogenomics Journal (2012) 12, 134–146; doi:10.1038/tpj.2010.77 Elements were omitted from the Supplementary Information that accompanied the online version of this article. For Supplementary Table 1, the following information should have been included: ‘A list of 121 genes up- or downregulated during first 4 weeks of intramuscular IFN-β-1a treatment.
引用
收藏
页码:360 / 360
页数:1
相关论文
共 50 条
  • [21] Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis:: A preliminary study
    Minagar, Alireza
    Adamashvili, Irena
    Kelley, Roger E.
    Gonzalez-Toledo, Eduardo
    McLarty, Jerry
    Smith, Stacy J.
    JOURNAL OF NEUROINFLAMMATION, 2007, 4 (1)
  • [22] Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study
    Alireza Minagar
    Irena Adamashvili
    Roger E Kelley
    Eduardo Gonzalez-Toledo
    Jerry McLarty
    Stacy J Smith
    Journal of Neuroinflammation, 4
  • [23] A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients
    Mallucci, Giulia
    Patti, Francesco
    Morra, Vincenzo Brescia
    Buccafusca, Maria
    Moiola, Lucia
    Amato, Maria Pia
    Ferraro, Elisabetta
    Trojano, Maria
    Zaffaroni, Mauro
    Mirabella, Massimiliano
    Moscato, Gianluca
    Plewnia, Katrin
    Zipoli, Valentina
    Puma, Elisa
    Bergamaschi, Roberto
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 40
  • [24] Subcutaneous Recombinant Interferon-β-1a (Rebif®) A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Sanford, Mark
    Lyseng-Williamson, Katherine A.
    DRUGS, 2011, 71 (14) : 1865 - 1891
  • [25] Subcutaneous Recombinant Interferon-β-1a (Rebif®)A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Mark Sanford
    Katherine A. Lyseng-Williamson
    Drugs, 2011, 71 : 1865 - 1891
  • [26] Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results
    A. Ghezzi
    M. P. Amato
    M. Capobianco
    P. Gallo
    M. G. Marrosu
    V. Martinelli
    C. Milanese
    L. Moiola
    N. Milani
    L. La Mantia
    F. Patti
    C. Pozzilli
    M. Trojano
    G. Comi
    M. Zaffaroni
    Neurological Sciences, 2007, 28 : 127 - 132
  • [27] Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a:: long-term results
    Ghezzi, A.
    Amato, M. P.
    Capobianco, M.
    Gallo, P.
    La Mantia, L.
    Marrosu, M. G.
    Martinelli, V.
    Milani, N.
    Milanese, C.
    Moiola, L.
    Patti, F.
    Pozzilli, C.
    Trojano, M.
    Zaffaroni, M.
    Comi, G.
    NEUROLOGICAL SCIENCES, 2007, 28 (03) : 127 - 132
  • [28] Prediction of treatment response to Interferon-β-1a based on MRI analysis at month 6
    de Vero, A
    Bacelar, O
    Schoetzau, A
    Hardmeier, M
    Gass, A
    Kappos, L
    Radü, EW
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S228 - S228
  • [29] The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing–Remitting Multiple Sclerosis
    Laurenske A. Visser
    Marc Folcher
    Claudia Delgado Simao
    Biotza Gutierrez Arechederra
    Encarna Escudero
    Carin A. Uyl-de Groot
    William Ken Redekop
    PharmacoEconomics, 2022, 40 : 91 - 108
  • [30] Comparison of response to treatment with interferon β-1a in African American and Caucasian American multiple sclerosis patients
    Cree, B
    Goodin, D
    Oksenberg, J
    Barcellos, L
    Hauser, S
    ANNALS OF NEUROLOGY, 2003, 54 : S34 - S35